The law does not adequately consider a patient s chance of survival and increases the risk that changes to the therapeutic aim will result in a lawsuit, according to one physician.
Results from the BOX randomized trial show no difference in outcomes with 36 vs 72 hours of cooling, and challenge current guidelines for fever prevention after out-of-hospital cardiac arrest.
A call to action has been issued for clinicians and US guidelines committees to reevaluate the utility of DPYD testing before administering fluoropyrimidine (FP) chemotherapy, but not everyone agrees.
Similar short-term clinical outcomes were achieved with hearts donated after circulatory death to those after brain death, and these could potentially increase the donor pool by 30%.